Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Publication year range
1.
Kyobu Geka ; 75(13): 1130-1134, 2022 Dec.
Article in Japanese | MEDLINE | ID: mdl-36539231

ABSTRACT

We report a case of distant metastases developed 32 years after radical mastectomy for right breast cancer. A 70s-year-old women visited the local hospital because of productive cough. Chest computed tomography (CT) showed a 10 mm nodule in the right middle lobe, multiple lymph nodes swelling and small pleural nodules. Surgical biopsy of lung and pleural tumor provides the pathological diagnosis of solid-tubular carcinoma expressing estrogen receptor and progesterone receptor, suggesting metastatic lesions of breast cancer.


Subject(s)
Breast Neoplasms , Carcinoma , Female , Humans , Aged , Breast Neoplasms/surgery , Breast Neoplasms/pathology , Mastectomy/methods , Lung/pathology , Lymph Nodes/pathology , Mastectomy, Radical , Carcinoma/surgery
2.
Surg Case Rep ; 8(1): 169, 2022 Sep 14.
Article in English | MEDLINE | ID: mdl-36103018

ABSTRACT

BACKGROUND: Pancreatic cancer (PC) is a highly lethal malignancy, even if surgical resection is possible (median survival: < 30 months). The prognosis of borderline resectable pancreatic cancer (BR-PC) is even worse. There is no clear consensus on the optimal treatment strategy, including pre/postoperative therapy, for BR-PC. We report a patient with BR-PC who achieved clinical partial response with neoadjuvant chemoradiation therapy (NACRT) and underwent curative resection, resulting in pathological complete response (pCR). CASE PRESENTATION: A 71-year-old man with jaundice and liver dysfunction was referred to our department because of a 48-mm hypo-vascular mass in the pancreatic head with obstruction of the pancreatic and bile ducts and infiltration of superior mesenteric vein and portal vein. The lesion was identified as atypical cells which suggested adenocarcinoma by biopsy, and he was administered NACRT: gemcitabine and nab-paclitaxel, following S-1 and intensity modulated radiation therapy. After reduction in the tumor size (clinical partial response), pancreaticoduodenectomy was performed, and pCR achieved. Postoperative adjuvant chemotherapy with S-1 was initially administered and the patient is currently alive with no recurrence as of 2 years after surgery. CONCLUSIONS: NACRT is a potentially useful treatment for BR-PC that may lead to pCR and help improve prognosis.

3.
Clin Case Rep ; 10(7): e6024, 2022 Jul.
Article in English | MEDLINE | ID: mdl-35846939

ABSTRACT

This article reports a clinical and histopathological perspective which noted not only COVID-19 pneumonia but also exacerbation of chronic renal failure potentially caused by thrombus in the kidney, possibly COVID-19-related lesions. The accumulation of autopsy cases will elucidate the pathogenesis of COVID-19 and aid in the development of effective therapeutics.

4.
Gan To Kagaku Ryoho ; 49(13): 1768-1770, 2022 Dec.
Article in Japanese | MEDLINE | ID: mdl-36732993

ABSTRACT

A 68-year-old woman with a chief complaint of obstructive jaundice was referred to our hospital. She was diagnosed with gallbladder cancer with invasion to the liver, extrahepatic bile duct, right hepatic artery and portal vein. After endoscopic retrograde biliary drainage, she received chemotherapy with gemcitabine and cisplatin. After 9 courses, the size of the tumor and the lymph nodes decreased, and we planned surgery. There were no unresectable factors, and the right hepatic artery and portal vein were detached from the tumor. We performed a subtotal stomach-preserving pancreaticoduodenectomy and gallbladder bed resection. We then performed adjuvant chemotherapy with S-1 for 1 year. The patient remains alive without recurrence, 5 years after the surgery. We report the case of advanced gallbladder cancer with downstaging after GC therapy.


Subject(s)
Gallbladder Neoplasms , Female , Humans , Aged , Gallbladder Neoplasms/drug therapy , Gallbladder Neoplasms/surgery , Gallbladder Neoplasms/pathology , Gemcitabine , Cisplatin , Combined Modality Therapy , Antineoplastic Combined Chemotherapy Protocols/therapeutic use
5.
BMC Res Notes ; 11(1): 34, 2018 Jan 16.
Article in English | MEDLINE | ID: mdl-29338781

ABSTRACT

BACKGROUND: Clinically amyopathic dermatomyositis with anti-Melanoma Differentiation-Associated gene 5 (MDA5) antibody often presents with severe interstitial lung disease. Although serum ferritin level is known to reflect interstitial lung disease activity, there are few case reports describing this association. CASE PRESENTATION: A 58-year-old man was referred to our outpatient clinic with a 3-week history of cough and respiratory distress. He had erythema over the V area of the neck and a Gottron's sign. Chest computed tomography revealed diffuse ground-glass opacities and reticular shadows in both lungs. Test for anti-MDA5 antibody was positive. After admission, he received triple combination therapy (methylprednisolone pulse therapy, tacrolimus, and cyclophosphamide). However, his respiratory condition worsened as the serum ferritin level increased. Despite no apparent deterioration on chest radiography, he ultimately died due to respiratory failure. CONCLUSIONS: In this case, triple combination therapy was not effective for the patient's respiratory condition. The serum ferritin level was correlated with disease activity and was more useful than chest radiography for monitoring clinical status.


Subject(s)
Dermatomyositis/pathology , Ferritins/blood , Lung Diseases, Interstitial/pathology , Anti-Inflammatory Agents/therapeutic use , Cyclophosphamide/therapeutic use , Dermatomyositis/complications , Dermatomyositis/drug therapy , Disease Progression , Drug Therapy, Combination , Fatal Outcome , Humans , Immunosuppressive Agents/therapeutic use , Lung Diseases, Interstitial/complications , Lung Diseases, Interstitial/drug therapy , Male , Methylprednisolone/therapeutic use , Middle Aged , Severity of Illness Index , Tacrolimus/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...